2011
DOI: 10.3233/jad-2011-110329 View full text |Buy / Rent full text
|
|

Abstract: The quantitative analysis of peptides in human cerebrospinal fluid (CSF) has become an important step in the early diagnosis of dementia, e.g., Alzheimer's disease. In search of new biomarkers for early detection and differential diagnosis of chronic neurodegenerative diseases, "biobanking" and long-term storage of human samples is increasingly important. The German Dementia Competence Network (DCN) has accomplished one of the largest biomaterial banks in this field, comprising CSF from several hundreds of pat… Show more

Help me understand this report

Search citation statements

Order By: Relevance
0
0
0
0
0
1
18
0

Publication Types

Select...

Relationship

0
0

Authors

Journals